TapewireFind a company

person · Reporting owner

Hrkac Frederick

Disclosed activity across 1 company

Tapewire entity
80400
SEC CIK
0001933130

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Streamex Corp.BSGM · Entity 1816DirectorApril 24, 2025April 29, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Streamex Corp.

Report date April 24, 2025 · Filed April 29, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect612,846 Reported balance After 2025-04-24 transaction · row 1
1 source row

Row 1 · 2025-04-24 · Grant · Acquired 23,345 · Balance 612,846

F1: The shares of common stock were granted under the Company's 2023 Equity Incentive Plan in lieu of cash for Q4 2024 and Q1 2025 board fees and were fully vested as of April 24, 2025 (the "Date of Grant"), based on a closing price of $0.84 per share on such date.

Filing footnotes · ownership attribution and instrument terms

F1: The shares of common stock were granted under the Company's 2023 Equity Incentive Plan in lieu of cash for Q4 2024 and Q1 2025 board fees and were fully vested as of April 24, 2025 (the "Date of Grant"), based on a closing price of $0.84 per share on such date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
April 24, 2025 Filed Apr 29, 2025 06:28 UTC Streamex Corp. BSGM · Entity 1816 GrantCommon Stock 23,345 $0.00 $0.00
Disclosure

SEC source: 0001641172-25-006567 · ownership.xml · nonDerivative · entry 1

Hrkac Frederick · CIK 0001933130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 612,846

F1 · price: The shares of common stock were granted under the Company's 2023 Equity Incentive Plan in lieu of cash for Q4 2024 and Q1 2025 board fees and were fully vested as of April 24, 2025 (the "Date of Grant"), based on a closing price of $0.84 per share on such date.

Read SEC document
July 26, 2024 Filed Jul 30, 2024 21:22 UTC Streamex Corp. BSGM · Entity 1816 GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-029661 · ownership.xml · nonDerivative · entry 1

Hrkac Frederick · CIK 0001933130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 589,501

F1 · price: The shares of restricted stock were granted for services and were fully vested as of July 26, 2024, the date of the grant, based on a closing price of $0.41 per share.

Read SEC document
June 07, 2024 Filed Jul 5, 2024 16:00 UTC Streamex Corp. BSGM · Entity 1816 GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-026333 · ownership.xml · nonDerivative · entry 1

Hrkac Frederick · CIK 0001933130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 559,501

F1 · price: The shares of restricted stock were granted for services and were fully vested as of June 7, 2024, the date of the grant, based on a closing price of $1.865 per share.

Read SEC document
March 01, 2024 Filed Mar 4, 2024 20:04 UTC Streamex Corp. BSGM · Entity 1816 GrantCommon Stock 500,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-008758 · ownership.xml · nonDerivative · entry 1

Hrkac Frederick · CIK 0001933130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 509,501

F1 · price: The shares of restricted stock were granted for services and shall be fully vested as of March 1, 2024 the date of the grant, based on a closing price of $0.705 per share.

F2 · balance_after: The amount reflects Mr. Hrkac's beneficial ownership of Common Stock post reverse split which went into effect on February 2, 2024.

Read SEC document
December 28, 2023 Filed Jan 4, 2024 16:05 UTC Streamex Corp. BSGM · Entity 1816 GrantRestricted Stock Units · Derivative 900,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-001076 · ownership.xml · derivative · entry 2

Hrkac Frederick · CIK 0001933130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 900,000

Underlying: Common Stock · 900,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the right to receive, at settlement, one (1) share of common stock.

F3 · derivative.exercise_date: This RSU award was granted on December 28, 2023. Upon the issuer's market valuation of $50,000,000, three hundred thousand (300,000) RSUs shall vest and upon the issuer's market valuation of $100,000,000, six hundred thousand (600,000) RSUs shall vest, subject to the terms and conditions of the BioSig Technologies, Inc. 2023 Long-Term Incentive Plan and the issuer's standard form of Restricted Stock Unit Award Agreement, provided that the Reporting Person is still providing services to the issuer or a subsidiary on such vesting dates. Notwithstanding the foregoing, upon the occurrence of (i) a change in control, or (ii) a termination of service due to death or total and permanent disability, all unvested RSUs shall immediately become vested RSUs.

F3 · derivative.expiration_date: This RSU award was granted on December 28, 2023. Upon the issuer's market valuation of $50,000,000, three hundred thousand (300,000) RSUs shall vest and upon the issuer's market valuation of $100,000,000, six hundred thousand (600,000) RSUs shall vest, subject to the terms and conditions of the BioSig Technologies, Inc. 2023 Long-Term Incentive Plan and the issuer's standard form of Restricted Stock Unit Award Agreement, provided that the Reporting Person is still providing services to the issuer or a subsidiary on such vesting dates. Notwithstanding the foregoing, upon the occurrence of (i) a change in control, or (ii) a termination of service due to death or total and permanent disability, all unvested RSUs shall immediately become vested RSUs.

Read SEC document
December 28, 2023 Filed Jan 4, 2024 16:05 UTC Streamex Corp. BSGM · Entity 1816 GrantStock Option (Right to Buy) · Derivative 600,000 $0.00 Strike: $0.47 $0.00
Disclosure

SEC source: 0001493152-24-001076 · ownership.xml · derivative · entry 1

Hrkac Frederick · CIK 0001933130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 600,000

Underlying: Common Stock · 600,000 shares

Expires 2033-12-27

F1 · derivative.exercise_date: One hundred thousand (100,000) of the shares of common stock underlying the stock option shall vest on each monthly anniversary of the date of grant for six consecutive months, provided that the Reporting Person is still providing services to the issuer or a subsidiary on such vesting dates.

Read SEC document
August 15, 2023 Filed Aug 18, 2023 19:04 UTC Streamex Corp. BSGM · Entity 1816 GrantCommon Stock 16,000 $0.00 $0.00
Disclosure

SEC source: 0001185185-23-000881 · ownership.xml · nonDerivative · entry 1

Hrkac Frederick · CIK 0001933130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,999

F1 · price: The shares of restricted stock were granted in lieu of remuneration for the Company's 2023 second quarter board fees and shall be fully vested as of August 15, 2023, the date of the grant, based on a closing price of $0.6364 per share on such date.

Read SEC document
April 20, 2023 Filed Apr 21, 2023 16:32 UTC Streamex Corp. BSGM · Entity 1816 GrantCommon Stock 17,544 $0.00 $0.00
Disclosure

SEC source: 0001185185-23-000402 · ownership.xml · nonDerivative · entry 1

Hrkac Frederick · CIK 0001933130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,999

F1 · price: The shares of restricted stock were granted in lieu of remuneration for the Company's 2023 first quarter board fees and shall be fully vested as of April 20, 2023, the date of the grant, based on a closing price of $1.32 per share on such date.

Read SEC document
February 24, 2023 Filed Feb 28, 2023 18:41 UTC Streamex Corp. BSGM · Entity 1816 GrantCommon Stock 12,000 $0.00 $0.00
Disclosure

SEC source: 0001185185-23-000172 · ownership.xml · nonDerivative · entry 1

Hrkac Frederick · CIK 0001933130 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,455

F1 · price: The shares of restricted stock were granted in lieu of remuneration for the Company's 2022 fourth quarter board fees and shall be fully vested as of February 24, 2023, the date of the grant, based on a closing price of $1.19 per share on such date.

Read SEC document
February 24, 2023 Filed Apr 21, 2023 16:30 UTC Amendment Streamex Corp. BSGM · Entity 1816 GrantCommon Stock 16,000 $0.00 $0.00
Disclosure

SEC source: 0001185185-23-000398 · ownership.xml · nonDerivative · entry 1

Hrkac Frederick · CIK 0001933130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,455

F2 · shares: On February 28, 2023, the reporting person filed a Form 4 which inadvertently reported a grant of 12,000 shares of restricted stock in lieu of remuneration for the Company's 2022 fourth quarter board fees when in fact, as reported in this amendment, the reporting person was granted 16,000 shares of restricted stock, and therefore beneficially owned 61,455 shares following the reported transaction.

F1 · price: The shares of restricted stock were granted in lieu of remuneration for the Company's 2022 fourth quarter board fees and shall be fully vested as of February 24, 2023, the date of the grant, based on a closing price of $1.19 per share on such date.

F2 · balance_after: On February 28, 2023, the reporting person filed a Form 4 which inadvertently reported a grant of 12,000 shares of restricted stock in lieu of remuneration for the Company's 2022 fourth quarter board fees when in fact, as reported in this amendment, the reporting person was granted 16,000 shares of restricted stock, and therefore beneficially owned 61,455 shares following the reported transaction.

Read SEC document
November 18, 2022 Filed Nov 22, 2022 20:05 UTC Streamex Corp. BSGM · Entity 1816 GrantCommon Stock 45,455 $0.00 $0.00
Disclosure

SEC source: 0001185185-22-001349 · ownership.xml · nonDerivative · entry 1

Hrkac Frederick · CIK 0001933130 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,455

F1 · price: The shares of restricted stock were granted in lieu of remuneration for the Company's third quarter board meeting and shall be fully vested as of November 18, 2022, the date of the grant, based on a closing price of $0.44 per share.

Read SEC document
May 12, 2022 Filed Jun 21, 2022 17:01 UTC Streamex Corp. BSGM · Entity 1816 GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $0.82 $0.00
Disclosure

SEC source: 0001185185-22-000764 · ownership.xml · derivative · entry 1

Hrkac Frederick · CIK 0001933130 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2032-05-12

F1 · derivative.exercise_date: 50% of the shares underlying this stock option vested and became exercisable immediately on the date of grant and 50% will vest and become exercisable on the first anniversary of the date of the director appointment on April 28, 2022, provided Mr. Hrkac is still serving as a director on such date and subject to the terms and conditions of the BioSig Technologies, Inc. 2012 Equity Incentive Plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.